Summary
OPTISOCHEM goal is to demonstrate the performances, reliability as well as environmental and socio-economic sustainability of the entire value chains, for the transformation of excess wheat straw into bio-Isobutene (bio-IBN) derivatives. To achieve these goals a team of 6 partners, leaders in their field, originating from 4 EU-member states, will join efforts.
OPTISOCHEM consists in showcasing the technical accessibility and economical sustainability of the value chains, from wheat straw to 2 different families of chemicals derived from bio-based IBN.
These compounds, oligomers (DIB, TIB, TeIB) and polyisobutylenes (PIBs) are currently used in a wide range of applications such as lubricants, adhesives, sealants, flavors & fragrances and substituted phenols.
This large market is today supplied entirely by products derived from fossil-based isobutene. Products derived from bio-based IBN, using the same process as fossil-based IBN, and with at least as good performances, would provide a renewable supply.
OPTISOCHEM includes the development & up-scaling of bio-IBN production from wheat straw, followed by the production and validation at relevant scale -representative of commercial, established processes- of the bio-based derivatives. To this end, four ambitious objectives were defined:
-Demonstrate the production of wheat straw hydrolysate (WSH) and establish a quality standard to feed the IBN fermentation unit,
-Demonstrate the production of bio-IBN from WSH at pre-commercial scale,
-Demonstrate the quality of end products obtained with bio-IBN as a feedstock and using traditional commercial processes designed for fossil based IBN,
-Determine and validate the targeted technical, economic as well as environmental/social sustainability performances to be achieved for a commercial plant project.
Related Work packages, tasks, milestones and risks are considered in order to achieve these objectives.
OPTISOCHEM project is fully aligned with the call topic.
OPTISOCHEM consists in showcasing the technical accessibility and economical sustainability of the value chains, from wheat straw to 2 different families of chemicals derived from bio-based IBN.
These compounds, oligomers (DIB, TIB, TeIB) and polyisobutylenes (PIBs) are currently used in a wide range of applications such as lubricants, adhesives, sealants, flavors & fragrances and substituted phenols.
This large market is today supplied entirely by products derived from fossil-based isobutene. Products derived from bio-based IBN, using the same process as fossil-based IBN, and with at least as good performances, would provide a renewable supply.
OPTISOCHEM includes the development & up-scaling of bio-IBN production from wheat straw, followed by the production and validation at relevant scale -representative of commercial, established processes- of the bio-based derivatives. To this end, four ambitious objectives were defined:
-Demonstrate the production of wheat straw hydrolysate (WSH) and establish a quality standard to feed the IBN fermentation unit,
-Demonstrate the production of bio-IBN from WSH at pre-commercial scale,
-Demonstrate the quality of end products obtained with bio-IBN as a feedstock and using traditional commercial processes designed for fossil based IBN,
-Determine and validate the targeted technical, economic as well as environmental/social sustainability performances to be achieved for a commercial plant project.
Related Work packages, tasks, milestones and risks are considered in order to achieve these objectives.
OPTISOCHEM project is fully aligned with the call topic.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/744330 |
| Start date: | 01-06-2017 |
| End date: | 31-12-2022 |
| Total budget - Public funding: | 16 376 816,00 Euro - 9 755 493,00 Euro |
Cordis data
Original description
OPTISOCHEM goal is to demonstrate the performances, reliability as well as environmental and socio-economic sustainability of the entire value chains, for the transformation of excess wheat straw into bio-Isobutene (bio-IBN) derivatives. To achieve these goals a team of 6 partners, leaders in their field, originating from 4 EU-member states, will join efforts.OPTISOCHEM consists in showcasing the technical accessibility and economical sustainability of the value chains, from wheat straw to 2 different families of chemicals derived from bio-based IBN.
These compounds, oligomers (DIB, TIB, TeIB) and polyisobutylenes (PIBs) are currently used in a wide range of applications such as lubricants, adhesives, sealants, flavors & fragrances and substituted phenols.
This large market is today supplied entirely by products derived from fossil-based isobutene. Products derived from bio-based IBN, using the same process as fossil-based IBN, and with at least as good performances, would provide a renewable supply.
OPTISOCHEM includes the development & up-scaling of bio-IBN production from wheat straw, followed by the production and validation at relevant scale -representative of commercial, established processes- of the bio-based derivatives. To this end, four ambitious objectives were defined:
-Demonstrate the production of wheat straw hydrolysate (WSH) and establish a quality standard to feed the IBN fermentation unit,
-Demonstrate the production of bio-IBN from WSH at pre-commercial scale,
-Demonstrate the quality of end products obtained with bio-IBN as a feedstock and using traditional commercial processes designed for fossil based IBN,
-Determine and validate the targeted technical, economic as well as environmental/social sustainability performances to be achieved for a commercial plant project.
Related Work packages, tasks, milestones and risks are considered in order to achieve these objectives.
OPTISOCHEM project is fully aligned with the call topic.
Status
CLOSEDCall topic
BBI-2016-D07Update Date
26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
H2020-EU.3.2. SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy
